Pappagallo, G.L., and M. Rizzo. 2014. “Directness and Quality of Evidence of Bevacizumab Combined With Chemotherapy for Platinum-Resistant, Recurrent Ovarian Cancer in the AURELIA Trial:  ”. Cancer Breaking News 2 (2):39-41. https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/274.